TMCI stockholders re-elect directors and approve executive compensation at 2024 annual meeting

TREACE MEDICAL CONCEPTS, INC.

Elected John K. Bakewell (39.1M for), Richard W. Mott (40.2M for), John T. Treace (44.0M for) as Class III directors.
Advisory vote on executive compensation approved: 44.8M for, 4.0M against, 13.9K abstain.
Stockholders favored holding Say-on-Pay vote every 1 year (46.7M votes); board adopted annual frequency.
Ratified Grant Thornton as independent auditor for FY2024: 52.7M for, 2.1M against, 2.6K abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.